Does synovial sarcoma grade predict oncologic outcomes, and does a low‐grade variant exist?
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26838
Abstract: While historically aggressive, some synovial sarcomas (SS) are clinically indolent. This study sought to determine whether SS grade predicts oncologic outcomes and whether Grade 1 disease might exist. read more here.
Keywords: grade predict; outcomes low; oncologic outcomes; synovial sarcoma ... See more keywords
Does induction of labor at 41 weeks (early, mid or late) improve birth outcomes in low‐risk pregnancy? A nationwide propensity score‐matched study
Sign Up to like & getrecommendations! Published in 2023 at "Acta Obstetricia et Gynecologica Scandinavica"
DOI: 10.1111/aogs.14536
Abstract: This study aimed to assess whether induction of labor at 41 weeks of gestation improved perinatal outcomes in a low‐risk pregnancy compared with expectant management. read more here.
Keywords: labor weeks; risk pregnancy; low risk; induction labor ... See more keywords
Histological chorioamnionitis, antenatal steroids, and neonatal outcomes in very low birth weight infants: A nationwide study
Sign Up to like & getrecommendations! Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0224450
Abstract: Background The aim of this study was to investigate whether some associations between histological chorioamnionitis (HCA) and favorable neonatal outcomes might be linked to those of antenatal steroids (AS) by determining the separate as well… read more here.
Keywords: antenatal steroids; histological chorioamnionitis; study; outcomes low ... See more keywords
Rifampin-resistant/multidrug-resistant Tuberculosis in Alberta, Canada: Epidemiology and treatment outcomes in a low-incidence setting
Sign Up to like & getrecommendations! Published in 2021 at "PLoS ONE"
DOI: 10.1371/journal.pone.0246993
Abstract: Treatment of rifampin-monoresistant/multidrug-resistant Tuberculosis (RR/MDR-TB) requires long treatment courses, complicated by frequent adverse events and low success rates. Incidence of RR/MDR-TB in Canada is low and treatment practices are variable due to the infrequent experience… read more here.
Keywords: treatment; alberta canada; epidemiology; multidrug resistant ... See more keywords
Patient Characteristics and Clinical Outcomes with Low-Dose Dabigatran
Sign Up to like & getrecommendations! Published in 2017 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2017.00042
Abstract: Background/aims Dabigatran, an oral direct thrombin inhibitor, is used in patients with non-valvular atrial fibrillation to reduce thromboembolic events. Whereas the 150 mg dosing regimen has been extensively studied in clinical setting, to date, there is… read more here.
Keywords: low dose; clinical outcomes; patient characteristics; characteristics clinical ... See more keywords